STOCK TITAN

Silicom Ltd. (SILC) CEO sells 18,072 shares, keeps RSUs and large option grants

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

SILICOM LTD. President and CEO Liron Eizenman reported selling 18,072 ordinary shares on 2026-08-12 at a weighted average price of $48.53 per share in open-market or private transactions. After this sale, 9,928 ordinary shares are reported as held indirectly by a trustee under the company’s equity incentive plan.

In addition, the filing lists indirect holdings of 38,333 Restricted Share Units, each convertible into one ordinary share upon vesting, and share options over 100,000 ordinary shares at an exercise price of $16.42 expiring on 2032-06-18, plus options over 13,333 ordinary shares at $15.01 expiring on 2033-06-18.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Eizenman Liron
Role President and CEO
Sold 18,072 shs ($877K)
Type Security Shares Price Value
Sale Ordinary shares F1, F2 18,072 $48.53 $877K
holding Restricted Share Units F3, F4, F2 -- -- --
holding Share Option (right to buy) F5, F2 -- -- --
holding Share Option (right to buy) F6, F2 -- -- --
Holdings After Transaction: Ordinary shares — 9,928 shares (Indirect, By Trustee); Restricted Share Units — 38,333 shares (Indirect, By Trustee); Share Option (right to buy) — 113,333 shares (Indirect, By Trustee)
Footnotes (6)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $48.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  2. F2. These securities are held by a trustee pursuant to the Issuer's equity incentive plan.
  3. F3. Each restricted share unit (RSU) represents the right to receive, following vesting, one share of the Issuer.
  4. F4. The grant of the RSUs have been approved by the Company's Compensation Committee and Board of Directors. Vesting of the RSUs will be subject to the grantee's achievement of the specified performance condition and continued service through each applicable vesting date, (a) 12,778 of the RSUs will vest and convert into ordinary shares one year after the grant date (which grant date is January 29, 2026), (b) 12,778 of the RSUs will vest and convert into ordinary shares on the second annual anniversary of the grant date and (c) 12,777 of the RSUs will vest and convert into ordinary shares on the three year anniversary of the grant date. If a vesting date falls on a non-business date, the next business date shall apply.
  5. F5. Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2024 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.
  6. F6. Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2025 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.
Shares sold 18,072 ordinary shares Sale by President and CEO Liron Eizenman on 2026-08-12
Weighted average sale price $48.53 per share Ordinary shares sold across $48.50–$48.56 range
Ordinary shares remaining 9,928 ordinary shares Indirectly held by trustee after reported sale
RSU underlying shares 38,333 ordinary shares Restricted Share Units indirectly held, each RSU equals one share
Option underlying shares (2024 grant) 100,000 ordinary shares Exercise price $16.42; expiration 2032-06-18
Option underlying shares (2025 grant) 13,333 ordinary shares Exercise price $15.01; expiration 2033-06-18
Restricted Share Units financial
"Each restricted share unit (RSU) represents the right to receive, following vesting, one share"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
equity incentive plan financial
"These securities are held by a trustee pursuant to the Issuer's equity incentive plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Grant Date financial
"The options were granted on June 18, 2024 (the "Grant Date") and will vest"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vesting financial
"Vesting of the RSUs will be subject to the grantee's achievement of the specified performance condition"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What insider transaction did SILICOM LTD. (SILC) report for Liron Eizenman?

Liron Eizenman reported selling 18,072 ordinary shares of SILICOM LTD. on 2026-08-12 at a weighted average price of $48.53. The sale was reported as an open-market or private transaction and the shares were held indirectly by a trustee.

How many SILICOM LTD. (SILC) shares does Liron Eizenman hold after the reported sale?

Following the sale, Liron Eizenman is reported as indirectly holding 9,928 ordinary shares of SILICOM LTD. These shares are held by a trustee under the company’s equity incentive plan, according to the filing’s ownership footnote.

What RSU holdings does Liron Eizenman report in SILICOM LTD. (SILC)?

The filing lists 38,333 Restricted Share Units (RSUs) indirectly held by Liron Eizenman. Each RSU represents the right to receive one SILICOM ordinary share upon vesting, subject to specified performance conditions and continued service through scheduled vesting dates.

What stock options does Liron Eizenman have in SILICOM LTD. (SILC)?

Liron Eizenman reports options over 100,000 ordinary shares at an exercise price of $16.42 expiring 2032-06-18 and options over 13,333 shares at $15.01 expiring 2033-06-18. These options vest in two equal tranches on the second and third anniversaries of their grant dates.

How was the sale price for SILICOM LTD. (SILC) shares determined in the Form 4?

The reported price of $48.53 per share is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.50 to $48.56. Full breakdowns are available on request from the issuer or SEC staff.

Are Liron Eizenman’s SILICOM LTD. (SILC) holdings direct or indirect?

The reported ordinary shares, RSUs, and options are all held indirectly “By Trustee” under SILICOM LTD.’s equity incentive plan. The filing characterizes these positions as indirect ownership rather than shares held directly in Eizenman’s own name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Eizenman Liron

(Last)(First)(Middle)
14 ATIR YEDA

(Street)
KFAR SAVA4464323

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
SILICOM LTD. [ SILC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary shares08/12/2026S18,072D$48.53(1)9,928IBy Trustee(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Share Units(3) (4) (4)Ordinary Shares38,33338,333IBy Trustee(2)
Share Option (right to buy)$16.42 (5)06/18/2032Ordinary Shares100,000100,000IBy Trustee(2)
Share Option (right to buy)$15.01 (6)06/18/2033Ordinary Shares13,33313,333IBy Trustee(2)
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $48.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
2. These securities are held by a trustee pursuant to the Issuer's equity incentive plan.
3. Each restricted share unit (RSU) represents the right to receive, following vesting, one share of the Issuer.
4. The grant of the RSUs have been approved by the Company's Compensation Committee and Board of Directors. Vesting of the RSUs will be subject to the grantee's achievement of the specified performance condition and continued service through each applicable vesting date, (a) 12,778 of the RSUs will vest and convert into ordinary shares one year after the grant date (which grant date is January 29, 2026), (b) 12,778 of the RSUs will vest and convert into ordinary shares on the second annual anniversary of the grant date and (c) 12,777 of the RSUs will vest and convert into ordinary shares on the three year anniversary of the grant date. If a vesting date falls on a non-business date, the next business date shall apply.
5. Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2024 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.
6. Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2025 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.
/s/ Eizenman Liron08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)